Italy will reserve AstraZeneca’s vaccine for the over 60s following considerations of a hyperlink to blood clots in youthful folks, the federal government’s high adviser on the coronavirus disaster introduced Wednesday.
The choice has been taken to “advocate the preferential use on people aged above 60”, Franco Locatelli advised reporters.
His announcement got here hours after the EU’s medicines regulator mentioned that blood clots must be listed as a uncommon aspect impact of the jab—however insisted the advantages proceed to outweigh the dangers.
Locatelli was talking at a swiftly convened information convention to elucidate the implications for Italy, one among a number of European nations that suspended using the AstraZeneca/Oxford jab final month however resumed utilizing it after the EMA dominated it was secure.
The World Well being Group’s vaccine consultants on Wednesday echoed EMA’s newest findings, saying a causal relationship between the vaccine and blood clots was “believable however isn’t confirmed”.
Locatelli, who coordinates the panel of consultants that advises the Italian authorities on coronavirus, mentioned the info on blood clots solely pointed to a hyperlink for folks receiving the primary dose.
Wednesday’s determination didn’t quantity to an outright ban on using the AstraZeneca jab on youthful cohorts of individuals.
For instance, Locatelli mentioned there must be no downside for these underneath the age of 60 receiving their second and ultimate dose of the vaccine.
Canada, France, Germany and the Netherlands are amongst a number of nations that aren’t recommending the AstraZeneca shot for youthful folks.
Observe the newest information on the coronavirus (COVID-19) outbreak
© 2021 AFP
Italy reserves AstraZeneca vaccine for over 60s (2021, April 7)
retrieved 7 April 2021
This doc is topic to copyright. Other than any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.